Published in Urologia on July 22, 2011
Prostate cancer with neuroendocrine differentiation--case report. J Med Life (2012) 0.75
A case of definitive therapy for localised prostate cancer: report of a urological nightmare. Adv Urol (2011) 0.75
Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol (2007) 3.26
Treatment of varicocele in subfertile men: The Cochrane Review--a contrary opinion. Eur Urol (2006) 2.18
Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis. Eur Urol (2003) 2.17
Prostate cancer gene 3 and multiparametric magnetic resonance can reduce unnecessary biopsies: decision curve analysis to evaluate predictive models. Urology (2013) 2.07
Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol (2011) 1.63
Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy. Urol Int (2008) 1.62
Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol (2007) 1.61
Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging. Eur Radiol (2013) 1.60
Smoking as a risk factor for erectile dysfunction: data from the Andrology Prevention Weeks 2001-2002 a study of the Italian Society of Andrology (s.I.a.). Eur Urol (2005) 1.52
Novel kidney segmentation system to describe tumour location for nephron-sparing surgery. World J Urol (2014) 1.39
Prostate growth and inflammation. J Steroid Biochem Mol Biol (2007) 1.33
Thulium laser supported nephron sparing surgery for renal cell carcinoma. J Urol (2013) 1.28
Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Anticancer Res (2003) 1.27
T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease. World J Gastroenterol (2011) 1.26
Real-time magnetic resonance-guided high-intensity focused ultrasound focal therapy for localised prostate cancer: preliminary experience. Eur Urol (2012) 1.23
Two-sided bulbar urethroplasty using dorsal plus ventral oral graft: urinary and sexual outcomes of a new technique. J Urol (2011) 1.20
Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Eur J Radiol (2011) 1.09
Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy. Clin Cancer Res (2010) 1.04
Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma. Prostate (2009) 0.97
Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer. Anticancer Res (2006) 0.95
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer. Int J Cancer (2014) 0.94
Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer. Cancer Invest (2010) 0.92
Characterization of circulating blood dendritic cell subsets DC123+ (lymphoid) and DC11C+ (myeloid) in prostate adenocarcinoma patients. Prostate (2007) 0.90
Long term patient satisfaction and quality of life with AMS700CX inflatable penile prosthesis. Arch Ital Urol Androl (2013) 0.89
Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer. BJU Int (2010) 0.89
The emerging role of targeted therapy in renal cell carcinoma (RCC): is it time for a neoadjuvant or an adjuvant approach? Crit Rev Oncol Hematol (2011) 0.88
Early recovery of urinary continence after radical prostatectomy using early pelvic floor electrical stimulation and biofeedback associated treatment. J Urol (2009) 0.88
Randomized trial comparing an anterograde versus a retrograde approach to open radical prostatectomy: results in terms of positive margin rate. Can Urol Assoc J (2010) 0.85
Management of urethral stent failure for recurrent anterior urethral strictures. Eur Urol (2009) 0.85
Supernumerary kidney laparoscopically treated. Can Urol Assoc J (2013) 0.85
Superselective embolization of bladder arteries in the treatment of intractable bladder haemorrhage. Int J Urol (2005) 0.85
Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction. BJU Int (2004) 0.85
Postmortem-computed tomography and postmortem-computed tomography-angiography: a focused update. Radiol Med (2015) 0.84
Urethral pseudodiverticulum secondary to penile fracture and complete urethra dissection. Can Urol Assoc J (2013) 0.84
In vivo 3D neuroanatomical evaluation of periprostatic nerve plexus with 3T-MR Diffusion Tensor Imaging. Eur J Radiol (2013) 0.84
Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer. Urol Oncol (2009) 0.84
Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma. Prostate (2003) 0.83
Distribution of high chromogranin A serum levels in patients with nonmetastatic and metastatic prostate adenocarcinoma. Urol Int (2009) 0.83
Pain in the upper anterior-lateral part of the thigh in women affected by endometriosis: study of sensitive neuropathy. Fertil Steril (2013) 0.82
Premature ejaculation results in female sexual distress: standardization and validation of a new diagnostic tool for sexual distress. J Urol (2012) 0.82
Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer. Crit Rev Oncol Hematol (2012) 0.82
Decrease of signal intensity of myometrium and cervical stroma after ultrasmall superparamagnetic iron oxide (USPIO) particles administration: an MR finding with potential benefits in T staging of uterine neoplasms. Invest Radiol (2004) 0.82
Functional magnetic resonance in the evaluation of oesophageal motility disorders. Gastroenterol Res Pract (2011) 0.82
Accuracy of MRI skeletal age estimation for subjects 12-19. Potential use for subjects of unknown age. Int J Legal Med (2015) 0.81
Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate. Urology (2005) 0.81
2D and 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy with erectile function correlation. Eur Radiol (2008) 0.81
Bladder cancer: a simple model becomes complex. Curr Genomics (2012) 0.81
Update on screening in prostate cancer based on recent clinical trials. Rev Recent Clin Trials (2011) 0.81
p53 gene mutational rate, Gleason score, and BK virus infection in prostate adenocarcinoma: Is there a correlation? J Med Virol (2008) 0.81
Recurrent transitional cell carcinoma of the bladder: A mixed nested variant case report and literature review. Can Urol Assoc J (2012) 0.81
New anti-angiogenic targeted therapy in advanced renal cell carcinoma (RCC): current status and future prospects. Rev Recent Clin Trials (2008) 0.80
Use of multiparametric MR with neurovascular bundle evaluation to optimize the oncological and functional management of patients considered for nerve-sparing radical prostatectomy. J Sex Med (2012) 0.80
Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery. Urol Oncol (2011) 0.80
Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR). Urol Oncol (2011) 0.80
Knotless "three-U-stitches" technique for urethrovesical anastomosis during laparoscopic radical prostatectomy. Int J Urol (2012) 0.80